Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 5/20 | 0.59 |
| ▸ | GAA | P10253 | 4/20 | 0.59 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.57 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.57 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | PARP1 | P09874 | 1/20 | 0.57 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.57 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | GFER | P55789 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL103227 | 1.00 | SMN1; SMN2 (0.63) | SMN1; SMN2ALDH1A1RAB9AGAAPARP10 | |
| SCHEMBL3052606 | 0.94 | LMNA (0.65) | SMN1; SMN2ALDH1A1RAB9AGAAPARP10 | |
| SCHEMBL3052608 | 0.94 | LMNA (0.65) | SMN1; SMN2ALDH1A1RAB9AGAAPARP10 | |
| SCHEMBL18796192 | 0.89 | PTGIR (0.65) | SMN1; SMN2ALDH1A1RAB9AGAAPARP10 | |
| SCHEMBL23864974 | 0.83 | KDM4E (0.56) | SMN1; SMN2ALDH1A1RAB9AGAAPARP10 | |
| SCHEMBL14970879 | 0.81 | PARP10 (0.55) | SMN1; SMN2ALDH1A1RAB9AGAAPARP10 | |
| SCHEMBL9892335 | 0.81 | PRSS1 (0.61) | SMN1; SMN2ALDH1A1RAB9AGAAPARP10 | |
| SCHEMBL21215222 | 0.81 | KDM1A (0.60) | ALDH1A1RAB9AGAALMNAKMT2A | |
| SCHEMBL18615326 | 0.80 | GAA (0.56) | SMN1; SMN2ALDH1A1RAB9AGAAPARP10 | |
| SCHEMBL5423613 | 0.79 | NOS3 (0.68) | SMN1; SMN2ALDH1A1RAB9AGAAPARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12180172-B1 | [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound | King Faisal University (SA) | 2024-12-31 | — | — | US | claimed |
| US-11981647-B1 | 3-(4-methoxyphenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound | King Faisal University (SA) | 2024-05-14 | — | — | US | claimed |
| US-11897850-B1 | N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-4-methoxybenzimidamide as an antimicrobial compound | King Faisal University (SA) | 2024-02-13 | — | — | US | claimed |
| US-11891366-B1 | 4-methoxy-n′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound | King Faisal University (SA) | 2024-02-06 | — | — | US | claimed |
| WO-2025224512-A1 | NOVEL COMPOUND AS 17-BETA-HYDROXYSTEROID DEHYDROGENASE 13 (HSD17B13) INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 삼진제약주식회사 | 2025-10-30 | — | — | WO | disclosed |
| US-12448372-B2 | Class of triaromatic compounds targeting bifunctional phosphorylation site of STAT3 and applications thereof | Shanghai Yuyao Biotech Ltd. (CN) | 2025-10-21 | — | — | US | disclosed |
| EP-4463452-B1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC (US) | 2025-07-30 | — | — | EP | disclosed |
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | ANIMA BIOTECH INC. (US) | 2025-07-01 | — | — | US | disclosed |
| EP-3634403-B1 | PHENYL-HETEROCYCLE-PHENYL DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF MELANOMA | MAX PLANCK GESELLSCHAFT (DE) | 2025-06-25 | — | — | EP | disclosed |
| US-12275723-B2 | Compounds and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2025-04-15 | — | — | US | disclosed |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2025-04-03 | — | — | US | disclosed |
| US-20250091999-A1 | [3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]METHANOL AS AN ANTITUMOR AND ANTIMICROBIAL COMPOUND | UNIV KING FAISAL (SA) | 2025-03-20 | — | — | US | disclosed |
| WO-1995016686-A1 | HETEROARYL MUPIROCIN DERIVATIVES USEFUL AS ANTIBACTERIAL, ANTIFUNGAL OR HERBICIDAL AGENTS | SMITHKLINE BEECHAM PLC (GB) | 1995-06-22 | — | — | WO | disclosed |
| US-5364865-A | Phenoxy- and phenoxyalkyl-piperidines as antiviral agents | STERLING WINTHROP INC. (US) | 1994-11-15 | — | — | US | disclosed |
| EP-0605031-A1 | Phenoxy- and phenoxyalkyl-piperidines as antiviral agents | STERLING WINTHROP INC. (US) | 1994-07-06 | — | — | EP | disclosed |
| US-4853383-A | β-blocking substituted imidazoles | MERCK & CO., INC. (US) | 1989-08-01 | — | — | US | disclosed |
| US-4642311-A | β-adrenergic blocking imidazolylphenoxy propanolamines | MERCK & CO., INC. (US) | 1987-02-10 | — | — | US | disclosed |
| US-4142044-A | FLUORESCENT DYES | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-02-27 | — | — | US | disclosed |
| US-4016170-A | TRANQUILIZERS, SLEEP INDUCERS | SANDOZ, INC. (US) | 1977-04-05 | — | — | US | disclosed |
| US-3994907-A | Coumarin derivatives, their preparation and their use as optical brightening agents | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11891366-B1 | 4-methoxy-n′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound | IL4I1, AADAC, CASP4 | SMN1; SMN2 2240/4885ALDH1A1 1134/4885RAB9A 3868/4885 |
| US-20250091999-A1 | [3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]METHANOL AS AN ANTITUMOR AND ANTIMICROBIAL COMPOUND | OXA1L, MCL1, CASP3 | SMN1; SMN2 2851/4885ALDH1A1 764/4885RAB9A 2683/4885 |
| US-12275723-B2 | Compounds and uses thereof | NLN, ACHE, CLN6 | SMN1; SMN2 13/4885ALDH1A1 656/4885RAB9A 2129/4885 |
| US-11897850-B1 | N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-4-methoxybenzimidamide as an antimicrobial compound | B3GNT2, IL4I1, NIT2 | SMN1; SMN2 3257/4885ALDH1A1 1271/4885RAB9A 3509/4885 |
| US-12448372-B2 | Class of triaromatic compounds targeting bifunctional phosphorylation site of STAT3 and applications thereof | STAT3, JAK2, STAT1 | SMN1; SMN2 4748/4885ALDH1A1 1654/4885RAB9A 3604/4885 |
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | MYC, MYCBP, MYCBP2 | SMN1; SMN2 3115/4885ALDH1A1 4471/4885RAB9A 2370/4885 |
| US-12180172-B1 | [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound | OXA1L, MCL1, CASP3 | SMN1; SMN2 2851/4885ALDH1A1 764/4885RAB9A 2683/4885 |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | MYC, MYCBP, MYCBP2 | SMN1; SMN2 3115/4885ALDH1A1 4471/4885RAB9A 2370/4885 |
| US-11981647-B1 | 3-(4-methoxyphenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound | OXA1L, API5, MCL1 | SMN1; SMN2 3510/4885ALDH1A1 1734/4885RAB9A 3147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.